NATURADE INC
10-Q, EX-27, 2000-08-14
PHARMACEUTICAL PREPARATIONS
Previous: NATURADE INC, 10-Q, EX-10.25, 2000-08-14
Next: STRATEGIA CORP, 10QSB, 2000-08-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                         285,755
<SECURITIES>                                         0
<RECEIVABLES>                                1,804,395
<ALLOWANCES>                                         0
<INVENTORY>                                  2,088,594
<CURRENT-ASSETS>                             4,700,408
<PP&E>                                         673,665
<DEPRECIATION>                                 371,150
<TOTAL-ASSETS>                               5,094,937
<CURRENT-LIABILITIES>                        4,832,712
<BONDS>                                              0
                                0
                                        125
<COMMON>                                           697
<OTHER-SE>                                 (3,600,122)
<TOTAL-LIABILITY-AND-EQUITY>                 5,094,937
<SALES>                                      7,058,783
<TOTAL-REVENUES>                             7,058,783
<CGS>                                        3,704,937
<TOTAL-COSTS>                                4,160,792
<OTHER-EXPENSES>                                24,537
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             388,757
<INCOME-PRETAX>                            (1,220,240)
<INCOME-TAX>                                       800
<INCOME-CONTINUING>                        (1,221,040)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (1,221,040)
<EPS-BASIC>                                     (0.18)
<EPS-DILUTED>                                   (0.18)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission